国际麻醉学与复苏杂志   2023, Issue (8): 0-0
    
艾司氯胺酮对腹腔镜减重手术患者苏醒质量及术后疼痛的影响
张靖悦, 郑惠文, 党静静, 王志萍1()
1.江苏省徐州医科大学
Effect of esketamine on the recovery outcome variables and postoperative pain in patients undergoing laparoscopic bariatric surgery.
 全文:
摘要:

【摘要】 目的 研究术中泵注艾司氯胺酮对腹腔镜下减重手术患者苏醒质量及术后疼痛的影响。方法 选取择期拟行腹腔镜下减重手术的肥胖患者64例,随机分为对照组和试验组,每组各32例。试验组采用术中泵注艾司氯胺酮0.5 mg·kg-1·h-1(浓度2.5mg·ml-1,输注速率即0.2 ml·kg-1·h-1),对照组以同等速率泵注等容量的生理盐水。比较两组自主呼吸恢复时间、苏醒时间、拔管时间、PACU驻留时间、改良Aldrete9分的时间、苏醒期间不良反应的发生率、补救镇痛。采用视觉模拟评分法(Visual Analogue Scale,VAS) 记录患者拔管即刻、术后6h、术后12h、术后24h疼痛情况。记录患者在麻醉前、麻醉诱导后5min、10min、15min、30min、拔管即刻、拔管后5min心率、血压变化以及围术期血管活性药物、降压药物的使用情况。 结果 试验组在术后6h、12h、24hVAS值均低于对照组,差异有统计学意义(P﹤0.05),两组在拔管即刻VAS评分没有统计学差异(P﹥0.05),在术毕自主呼吸恢复时间、苏醒时间、拔管时间、PACU驻留时间、停药后达改良Aldrete大于9分的时间上均无统计学差异(P﹥0.05),试验组麻醉苏醒期低氧血症发生率低于对照组,差异有统计学意义(P﹤0.05),其他苏醒期不良反应发生率均无统计学差异(P﹥0.05)。在T1时,两组平均动脉压存在统计学差异(P﹤0.05),其余时间段的平均动脉压无统计学差异(P﹥0.05),两组患者在不同时间段的心率,差异均无统计学意义(P﹥0.05)。试验组去氧肾上腺素使用率低于对照组(P﹤0.05),其余血管活性药物、降压药物的使用率无统计学差异(P﹥0.05)。结论 术中泵注艾司氯胺酮可有效缓解患者术后急性疼痛,稳定血流动力学,降低术后低氧血症发生,且不会影响患者术后苏醒质量。

关键词: 艾司氯胺酮 肥胖 腹腔镜减重手术 血流动力学 苏醒质量 术后疼痛
Abstract:

【Abstract】 Objective To explore the effects of intraoperative pumping of esketamine on the recovery outcome variables and postoperative pain in patients undergoing laparoscopic bariatric surgery. Methods Sixty-four obese patients undergoing elective laparoscopic bariatric surgery were randomly divided into control group or experimental group, with 32 patients in each group. In the experimental group, esketamine was pumped intraoperatively at the rate of 0.5 mg·kg-1·h-1 (concentration: 2.5 mg·ml-1, infusion rate i.e., 0.2 ml·kg-1·h-1). In the control group, equal volume of saline was pumped at the same rate. The time to extubation, spontaneous respiration, eye opening, modified Aldrete recovery 9 points(from discontinuation of remifentanil),duration of PACU stay and incidence of adverse events during awakening were compared between the two groups. The visual Analogue Scale (VAS) method was used to record the patients' pain immediately after extubation, 6h postoperatively, 12h postoperatively and 24h postoperatively. The changes in heart rate and blood pressure before anesthesia (T0), 5 minutes after induction of anesthesia (T1), 10 minutes (T2), 15 minutes (T3), 30 minutes (T4), immediately after extubation (T5), 5 minutes after extubation (T6), and the use of perioperative vasoactive drugs and antihypertensive drugs were recorded. Results The VAS values in the experimental group were lower than those of the control group at 6, 12 and 24 h after surgery, and the differences were statistically significant (P 0.05). There was no statistical difference between the two groups in the VAS scores immediately after extubation (P 0.05). There was no statistical difference in the recovery profile characteristics (P 0.05). The incidence of hypoxemia during the awakening period of anesthesia in the test group was lower than that in the control group, and the difference was statistically significant (P 0.05), and the incidence of other adverse reactions during the awakening period were not statistically different (P 0.05). At T1, there was a statistical difference in the mean arterial pressure between the two groups(P 0.05), and there was no statistical difference in the mean arterial pressure in the rest of the time period(P 0.05). The usage rate of phenylephrine in the test group was lower than that in the control group(P 0.05), and there was no statistical difference in the use of the other vasoactive drugs and antihypertensive drugs (P 0.05). Conclusion Intraoperative administration of esketamine has been shown to be an effective method for relieving acute postoperative pain, stabilizing hemodynamics, reducing the incidence of postoperative hypoxemia, and does not have a negative impact on the quality of postoperative awakening in patients.

Key words: Esketamine; Obesity; Laparoscopic Bariatric Surgery; Hemodynamics; Quality Of Recovery characteristics; Postoperative Pain